99 related articles for article (PubMed ID: 3488025)
1. [The influence of a biological response modifier on thoracic lymphocytes--a study involving clinical cases and animal experiments].
Hanaue H; Kurosawa T; Miyakawa S; Kitano Y; Nemoto A; Yamoto H; Asagoe T; Shikata J
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1285-9. PubMed ID: 3488025
[TBL] [Abstract][Full Text] [Related]
2. Effects of biological response modifier on thoracic duct lymphocytes in recurrent gastric cancer. Evaluation of OK-432, a hemolytic streptococcus preparation.
Hanaue H; Kim DY; Kubota M; Kurosawa T; Shikata J; Kondoh Y; Ogoshi K; Makuuchi H; Nakasaki H; Mitomi T
Tokai J Exp Clin Med; 1987 May; 12(2):97-102. PubMed ID: 3502432
[TBL] [Abstract][Full Text] [Related]
3. Effects of oral administration of streptococcal preparation OK-432 on thoracic duct lymphocytes.
Hanaue H; Kim DY; Machimura T; Tsukui M; Kubota M; Kurosawa T; Shikata J; Kondoh Y; Ogoshi K; Makuuchi H
Tokai J Exp Clin Med; 1987 Sep; 12(3):159-65. PubMed ID: 3502615
[TBL] [Abstract][Full Text] [Related]
4. [An immunological study on the effect of simultaneous intrahepatic injection of an immunomodulator (OK-432) and adriamycin--an experiment in rats].
Takada T; Yasuda H; Uchiyama K; Hasegawa H; Miura S; Asagoe T; Hanaue H; Shikata J
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2305-13. PubMed ID: 2934024
[TBL] [Abstract][Full Text] [Related]
5. [A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)].
Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):997-1012. PubMed ID: 2202770
[TBL] [Abstract][Full Text] [Related]
6. [Basic studies on the effects of oral administration of streptococcal preparation OK-432. I. Effects of thoracic duct lymphocytes].
Hanaue H; Kurosawa T; Nemoto A; Asagoe T; Shikata J
Nihon Gan Chiryo Gakkai Shi; 1987 Aug; 22(7):1348-53. PubMed ID: 3501454
[No Abstract] [Full Text] [Related]
7. [Influence of OK 432 upon postoperative alteration in activities producing lymphokines, IL 1, IL 2, and IFN, of peripheral blood mononuclear cells derived from patients with gastric cancer].
Hosoi J
Nihon Gan Chiryo Gakkai Shi; 1987 Apr; 22(3):603-13. PubMed ID: 2443588
[No Abstract] [Full Text] [Related]
8. [Immunological study on localized liver injection of immunopotentiator OK-432-- experimental studies in rats].
Takada T; Yasuda H; Uchiyama K; Hasegawa H
Gan To Kagaku Ryoho; 1984 Oct; 11(10):2267-71. PubMed ID: 6333213
[TBL] [Abstract][Full Text] [Related]
9. [Administration of hemolytic streptococcus preparation OK-432 on recurrent gastric carcinoma].
Hanaue H; Kurosawa T; Kitano Y; Miyagawa S; Nemoto A; Yamato H; Asagoe T; Shikata J
Nihon Gan Chiryo Gakkai Shi; 1987 Aug; 22(7):1367-72. PubMed ID: 3501455
[No Abstract] [Full Text] [Related]
10. Immunological parameters in gastric cancer patients treated with immunotherapy of streptococcal preparation OK-432.
Hanaue H; Nomoto S; Kimura T; Kutsuna T; Takeuchi T; Yoshizaki S
Keio J Med; 1982 Dec; 31(4):159-68. PubMed ID: 6985379
[No Abstract] [Full Text] [Related]
11. [Augmentation of cytotoxicity of regional lymph node lymphocytes of gastric cancer after intratumoral injection of OK-432].
Kobayashi G
Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):68-76. PubMed ID: 2314383
[TBL] [Abstract][Full Text] [Related]
12. [Su-polysaccharide skin test and immunotherapy with OK-432 in postoperative gastric cancer--the effect of a splenectomy].
Saito H; Kikkawa H; Bando H; Sakatoku M; Hirano M; Tatsuzawa T
Gan No Rinsho; 1988 Nov; 34(14):1965-8. PubMed ID: 3204664
[TBL] [Abstract][Full Text] [Related]
13. [Intratumoral administration of OK432 in rats with liver tumor].
Ishimaru M
Nihon Geka Gakkai Zasshi; 1988 Jun; 89(6):880-8. PubMed ID: 2972906
[TBL] [Abstract][Full Text] [Related]
14. [Immunotherapy, with OK-432 for cases of nasopharyngeal carcinoma].
Tsukuda M; Tamamushi N; Mochimatsu I; Mitarai K; Kaneko M; Sawaki S
Gan To Kagaku Ryoho; 1986 Jan; 13(1):53-9. PubMed ID: 3942399
[TBL] [Abstract][Full Text] [Related]
15. [Postoperative cell-mediated immunity in gastric cancer patients--with special reference to the effects of immunotherapy].
Sekizuka H; Noro K; Haruyama S; Kiribuchi Y; Hayashi F
Gan No Rinsho; 1985 Sep; 31(11):1381-6. PubMed ID: 3877822
[TBL] [Abstract][Full Text] [Related]
16. Search for immunomodulatory effects of blood transfusion in gastric cancer patients: flow cytometry of Th1/Th2 cells in peripheral blood.
Sun CF; Hsieh YY; Ngan KW; Wang WT
Ann Clin Lab Sci; 2001 Apr; 31(2):171-8. PubMed ID: 11337907
[TBL] [Abstract][Full Text] [Related]
17. [Endoscopic preoperative intralesional injection of OK-432 in early gastric cancer].
Yamane T; Sagara Y; Suzuki G; Kasuga M; Sakita M; Fujita Y; Majima S
Gan To Kagaku Ryoho; 1984 Apr; 11(4):930-4. PubMed ID: 6721507
[TBL] [Abstract][Full Text] [Related]
18. [Subpopulations of T and B lymphocytes in venous peripheral blood and blood draining from lesions in patients with gastroduodenal ulcer, and gastric and colonic cancer].
Rachel F; Rogozińska-Myśliwiec A
Wiad Lek; 1993 Jun; 46(11-12):433-40. PubMed ID: 8116293
[TBL] [Abstract][Full Text] [Related]
19. [The management of malignant ascites with a streptococcal preparation, OK-432: relation between the clinical effect and auto-tumor cell killing activity by OK-432-induced ascites-derived lymphocytes].
Katano M; Yamamoto H; Mizoguchi T; Hidaka K; Hisatsugu T; Torisu M
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2464-8. PubMed ID: 3497612
[TBL] [Abstract][Full Text] [Related]
20. [A multi-center trial of MY-1, a new biological response modifier, on the immunological parameters of postoperative gastric cancer patients].
Ochiai T; Sato H; Isono K; Uematsu T; Nakajima K; Mukai M; Asano T; Onoda S; Morioka Y; Danno M
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):959-69. PubMed ID: 3963860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
